Ethical and social policy issues raised by HIV screening: the epidemic evolves and so do the challenges.
Bayer
R
R
Division of Sociomedical Sciences, School of Public Health, Columbia University, New York, New York 10032.
D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology / Q000276:immunology; D001521:Behavior Therapy; D026686:Beneficence; D004311:Double-Blind Method; D004992:Ethics, Medical; D015483:HIV Antibodies / Q000032:analysis*; D006679:HIV Seropositivity / Q000175:diagnosis; D006801:Humans; D037141:Mandatory Programs; D015166:Monitoring, Immunologic; D028681:Moral Obligations; D026684:Personal Autonomy; D011634:Public Health; D011640:Public Policy; D018570:Risk Assessment; D014481:United States; D035141:Voluntary Programs
D015483:HIV Antibodies